Alumis ALMS
NASDAQ ALMS
$6.92 +0.22 (+3.21%)
As of: Oct 21, 2026 · 11:25 AM EDT

Alumis (ALMS) EBIT Margin (2025 - 2026)

Updated

Alumis' EBIT Margin came in at -8956.38% for Q2 2026, down 3684.85 percentage points from -5271.53% a year earlier.

Analysis

Alumis (ALMS) EBIT Margin (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Alumis reported EBIT Margin of -6021.04%; for FY2025, it came in at -1886.92%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,131.24 Bn 1,099.82 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 614.68 Bn 533.21 Bn 17.26 Bn 28.21%
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 37.86%
4 Merck 368.01 Bn 322.38 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.43 Bn 262.42 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn 20.57%
7 Amgen 236.03 Bn 191.43 Bn 7.24 Bn 34.95%
8 Gilead Sciences 190.92 Bn 165.12 Bn 6.22 Bn -133.21%
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn 28.37%
10 Alumis 879.85 Mn -794.99 Mn - -8,956.38%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,956.38%
Dec 31, 2025 -4,999.74%
Sep 30, 2025 -5,580.45%
Jun 30, 2025 -5,271.53%
Mar 31, 2025 -583.49%
API Access

Alumis EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALMS&period=max&api_key=YOUR_API_KEY